Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-16 Sale | 2023-06-20 5:06 pm | uniQure N.V. | QURE | Springhorn Jeremy P. Director | 2,286 | $18.88 | $43,160 | 43,047 (Direct) | View |
| 2023-02-27 Sale | 2023-03-01 4:12 pm | uniQure N.V. | QURE | Springhorn Jeremy P. Director | 384 | $20.41 | $7,837 | 19,573 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 5:39 pm | uniQure N.V. | QURE | Springhorn Jeremy P. Director | 602 | $16.7 | $10,053 | 10,877 (Direct) | View |
| 2021-03-02 Sale | 2021-03-04 1:53 pm | uniQure N.V. | QURE | Springhorn Jeremy P. Director | 505 | $37.5 | $18,938 | 9,945 (Direct) | View |
| 2020-01-28 Sale | 2020-01-30 8:57 pm | uniQure N.V. | QURE | Springhorn Jeremy P. Director | 807 | $62.19 | $50,190 | 6,005 (Direct) | View |
| 2019-11-11 Purchase | 2019-11-12 4:34 pm | Syros Pharmaceuticals Inc. | SYRS | Springhorn Jeremy P. Chief Business Officer | 20,000 | $4.9798 | $99,596 | 35,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-13 Option Award | 2023-06-20 5:06 pm | N/A 2033-06-13 | uniQure N.V. | QURE | Springhorn Jeremy P. Director | 25,760 | $0 | 43,047 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:18 pm | N/A 2032-06-15 | uniQure N.V. | QURE | Springhorn Jeremy P. Director | 26,890 | $0 | 37,767 (Direct) | View |
| 2022-02-24 Option Award | 2022-02-28 6:35 pm | N/A 2032-02-24 | uniQure N.V. | QURE | Springhorn Jeremy P. Director | 4,179 | $0 | 14,124 (Direct) | View |
| 2021-02-25 Option Award | 2021-03-01 4:06 pm | N/A 2031-02-25 | uniQure N.V. | QURE | Springhorn Jeremy P. Director | 6,489 | $0 | 14,557 (Direct) | View |
| 2021-02-17 Option Award | 2021-02-19 4:16 pm | N/A 2031-02-16 | Syros Pharmaceuticals Inc. | SYRS | Springhorn Jeremy P. Chief Business Officer | 94,000 | $0 | 94,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 3:59 pm | N/A 2030-02-27 | uniQure N.V. | QURE | Springhorn Jeremy P. Director | 5,683 | $0 | 11,688 (Direct) | View |
| 2020-02-13 Option Award | 2020-02-14 4:07 pm | N/A 2030-02-12 | Syros Pharmaceuticals Inc. | SYRS | Springhorn Jeremy P. Chief Business Officer | 94,000 | $0 | 94,000 (Direct) | View |